Assessment of the Embryonic Stem Cell Test and application and use in the pharmaceutical industry.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Birth defects research. Part B. Developmental and reproductice toxicology

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/bdrb.20148PMID 18361453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Practical Application of Three Validated In Vitro Embryotoxicity Tests

  2006cited by this paper
• Validation of the Embryonic Stem Cell Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests

  2004cited by this paper
• Can the pharmaceutical industry reduce attrition rates?

  2004cited by this paper
• Trends in improving the embryonic stem cell test (EST): an overview.

  2004cited by this paper
• Hematopoietic commitment of ES cells in culture.

  2003cited by this paper
• Selection of Test Chemicals for the ECVAM International Validation Study on In Vitro Embryotoxicity Tests

  2002cited by this paper
• Prevalidation of the Embryonic Stem Cell Test (EST)-A New In Vitro Embryotoxicity Test.

  1999cited by this paper
• A new embryonic stem cell line from DBA/1lacJ mice allows genetic modification in a murine model of human inflammation.

  1995cited by this paper
• Effect of sodium warfarin on vitamin K‐dependent proteins and skeletal development in the rat fetus

  1990cited by this paper

• Minimizing Use of Nonhuman Primates to Inform Risk to Fertility and of Adverse Pregnancy Outcomes with Pharmaceuticals

  2025cites this paper
• New approach methodologies for assessing developmental toxicity of pharmaceuticals: Case Examples and Future Directions.

  2025cites this paper
• Morphometric‐Assisted Prediction of Developmental Toxicity Using Stem Cell‐Based Embryo Models in Microwells

  2025cites this paper
• A developmental and reproductive toxicity adverse outcome pathway network to support safety assessments

  2024cites this paper
• New approach methodologies to confirm developmental toxicity of pharmaceuticals based on weight of evidence.

  2024cites this paper
• Innovating human chemical hazard and risk assessment through an holistic approach

  2023cites this paper
• Визначення можливої ембріотоксичної, фето- та ембріолетальної дії сполуки 4-((5-(децилтіо)-4-метил-4h-1,2,4-триазол-3-іл)-метил)морфоліну у постнатальному періоді

  2023cites this paper
• Enhancing developmental and reproductive toxicity knowledge: A new AOP stemming from glutathione depletion

  2023cites this paper
• The DevTox Germ Layer Reporter Platform: An Assay Adaptation of the Human Pluripotent Stem Cell Test

  2022cites this paper
• Reproductive and developmental safety evaluation of new pharmaceutical compounds

  2022cites this paper
• Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity

  2022cites this paper
• In vitro models of human development and their potential application in developmental toxicity testing.

  2022cites this paper
• Environmental Microbiology and Biotechnology: Volume 2: Bioenergy and Environmental Health

  2021cites this paper
• Environmental Interaction and Impact on the Life Span of Stem Cells

  2020cites this paper
• Inhibition of ACC causes malformations in rats and rabbits: comparison of mammalian findings and alternative assays.

  2020cites this paper
• An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds

  2020cites this paper
• Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4

  2020cites this paper
• Prenatal toxicity of the environmental pollutants on neuronal and cardiac development derived from embryonic stem cells.

  2019cites this paper
• Implications for the Predictivity of Cell-Based Developmental Toxicity Assays Developed Two Decades Apart

  2019cites this paper
• Droplet microarray: miniaturized platform for rapid formation and high-throughput screening of embryoid bodies.

  2018cites this paper
• The Validated Embryonic Stem Cell Test with Murine Embryonic Stem Cells.

  2018cites this paper
• Validation redefined.

  2018cites this paper
• Pluripotent Stem Cells in Developmental Toxicity Testing: A Review of Methodological Advances.

  2018cites this paper
• Stem Cells and Tissue Engineering Technologies for Advancing Human Teratogen Screening

  2018cites this paper
• KÖK HÜCRELERİN TOKSİKOLOJİ ÇALIŞMALARINDA KULLANIMI

  2018cites this paper
• Prospects and Frontiers of Stem Cell Toxicology

  2017cites this paper
• Editor’s Highlight: Development of Novel Neural Embryonic Stem CellTests for High-Throughput Screening of Embryotoxic Chemicals

  2017influential citation
• Developmental and Reproductive Toxicology

  2017cites this paper
• Embryotoxicity estimation of commonly used compounds with embryonic stem cell test

  2017cites this paper
• Application of Evolving Computational and Biological Platforms for Chemical Safety Assessment

  2017cites this paper
• Toxicity of nano- and ionic silver to embryonic stem cells: a comparative toxicogenomic study

  2017cites this paper
• Chapter 6 – Reproductive and Developmental Safety Evaluation of New Pharmaceutical Compounds

  2017cites this paper
• Alternative Models of Developmental and Reproductive Toxicity in Pharmaceutical Risk Assessment and the 3Rs.

  2016cites this paper
• Prediction of in vivo developmental toxicity by combination of Hand1-Luc embryonic stem cell test and metabolic stability test with clarification of metabolically inapplicable candidates.

  2016cites this paper
• Stem cell toxicology: a powerful tool to assess pollution effects on human health

  2016cites this paper
• Alternative Methods Used to Assess Potential Embryo-Fetal Developmental Risk of Pharmaceuticals

  2016cites this paper
• Guidelines for Preclinical Development

  2016cites this paper
• Osteogenic Differentiation of Human Embryonic Stem Cell-Derived Mesenchymal Progenitor Cells as a Model for Assessing Developmental Bone Toxicity In Vitro

  2016cites this paper
• Neural Differentiation of Human Pluripotent Stem Cells for Nontherapeutic Applications: Toxicology, Pharmacology, and In Vitro Disease Modeling

  2015cites this paper
• Evaluation of developmental toxicity using undifferentiated human embryonic stem cells

  2015cites this paper
• Animal Study Protocols and Alternative Assays for the Assessment of Reproductive and Developmental Toxicity

  2015cites this paper
• Developing osteoblasts as an endpoint for the mouse embryonic stem cell test.

  2015cites this paper
• Assessment of the embryotoxicity of four Chinese herbal extracts using the embryonic stem cell test.

  2015cites this paper
• Stem Cells in Toxicity Testing

  2014cites this paper
• Fishing for teratogens: a consortium effort for a harmonized zebrafish developmental toxicology assay.

  2014cites this paper
• Pluripotent Stem Cells as Tools to Assess Developmental Toxicity: Diversity Instead of Consolidation

  2014cites this paper
• Comparison of osteoblast and cardiomyocyte differentiation in the embryonic stem cell test for predicting embryotoxicity in vivo.

  2014cites this paper
• Three dimensional cellular microarray platform for human neural stem cell differentiation and toxicology.

  2014cites this paper
• A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment

  2014cites this paper
• Assessment of Developmental Toxicants using Human Embryonic Stem Cells

  2013cites this paper
• Teratogenicity Testing

  2013cites this paper
• The influence of dexamethasone administration on the protection against doxorubicin-induced cardiotoxicity in purified embryonic stem cell-derived cardiomyocytes.

  2013cites this paper
• The embryonic stem cell test.

  2013cites this paper
• Stem Cells and Stem Cell-derived Tissues and Their Use in Safety Assessment*

  2013cites this paper
• Innovations in testing strategies in reproductive toxicology.

  2013cites this paper
• Reevaluation of the Embryonic Stem Cell Test

  2013cites this paper
• Embryonic Stem Cell Test (EST): Molecular Endpoints Toward High‐Throughput Analysis of Chemical Embryotoxic Potential

  2013cites this paper
• The Use of Human Embryonic Stem Cells in High-Throughput Toxicity Assays

  2013cites this paper
• The Advent of the Golden Era of Animal Alternatives

  2013cites this paper
• Chapter 13 – Developmental and Reproductive Toxicology

  2013cites this paper
• Chapter 33 – Predictive Toxicology: Biological Assay Platforms

  2013cites this paper
• Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening.

  2013cites this paper
• Alternative models in developmental toxicology

  2012cites this paper
• Compound-specific effects of diverse neurodevelopmental toxicants on global gene expression in the neural embryonic stem cell test (ESTn).

  2012cites this paper
• Embryonic stem cells: An alternative approach to developmental toxicity testing

  2012cites this paper
• Toward in vitro biomarkers for developmental toxicity and their extrapolation to the in vivo situation

  2012cites this paper
• Development and implementation of alternative methods in reproductive toxicology

  2012cites this paper
• The chick cardiomyocyte micromass system and stem cell differentiation along specific pathways : prediction of embryotoxic effects and their mechanism

  2012cites this paper
• Enhancing the applicability and predictability of the embryonic stem cell test for developmental toxicity

  2012cites this paper
• Transcriptomic concentration-response evaluation of valproic acid, cyproconazole, and hexaconazole in the neural embryonic stem cell test (ESTn).

  2012cites this paper
• Assessment of technical protocols for novel embryonic stem cell tests with molecular markers (Hand1- and Cmya1-ESTs): a preliminary cross-laboratory performance analysis.

  2012cites this paper
• Embryotoxicity of Psoralea corylifolia L.: in vivo and in vitro studies.

  2012cites this paper
• Inter-laboratory assessment of a harmonized zebrafish developmental toxicology assay - progress report on phase I.

  2012cites this paper
• Could MDMA Promote Stemness Characteristics in Mouse Embryonic Stem Cells via mGlu5 Metabotropic Glutamate Receptors?

  2012cites this paper
• Adapting human pluripotent stem cells to high-throughput and high-content screening

  2012cites this paper
• Assaying embryotoxicity in the test tube: Current limitations of the embryonic stem cell test (EST) challenging its applicability domain

  2012influential citation
• Simvastatin modulates mouse embryonic stem cell-derived chondrogenesis in vitro.

  2012cites this paper
• Human pluripotent stem cells for modeling toxicity.

  2012cites this paper
• Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays?

  2011cites this paper
• The effects of Boehmeria nivea (L.) Gaud. on embryonic development: in vivo and in vitro studies.

  2011cites this paper
• Dose response analysis of monophthalates in the murine embryonic stem cell test assessed by cardiomyocyte differentiation and gene expression.

  2011cites this paper
• The Embryonic Stem Cell Test as Tool to Assess Structure-Dependent Teratogenicity: The Case of Valproic Acid

  2011cites this paper
• Opportunities for Use of Human iPS Cells in Predictive Toxicology

  2011cites this paper
• The validated embryonic stem cell test to predict embryotoxicity in vitro

  2011cites this paper
• Applications of stem cells in developmental toxicology

  2011cites this paper
• Alternatives to animal testing: current status and future perspectives

  2011cites this paper
• Drug discovery in Parkinson’s disease: update and developments in the use of cellular models

  2011cites this paper
• A critique of the EC's expert (draft) reports on the status of alternatives for cosmetics testing to meet the 2013 deadline.

  2011cites this paper
• Embryonic Stem Cells as a Tool for Drug Screening and Toxicity Testing

  2011cites this paper
• Primary Cells and Stem Cells in Drug Discovery: Emerging Tools for High-Throughput Screening

  2011cites this paper
• The embryonic stem cell test combined with toxicogenomics as an alternative testing model for the assessment of developmental toxicity.

  2011cites this paper
• Evaluation of novel high-throughput embryonic stem cell tests with new molecular markers for screening embryotoxic chemicals in vitro.

  2011cites this paper
• Defined culture medium for stem cell differentiation: applicability of serum-free conditions in the mouse embryonic stem cell test.

  2011cites this paper
• Not a walk in the park: the ECVAM whole embryo culture model challenged with pharmaceuticals and attempted improvements with random forest design.

  2011cites this paper
• Reproductive and Developmental Safety Evaluation of New Pharmaceutical Compounds

  2011cites this paper
• Mouse and human embryonic stem cells: can they improve human health by preventing disease?

  2011cites this paper
• Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010

  2011cites this paper
• Induced pluripotent stem cells: a new era for hepatology.

  2010cites this paper
• Editorial 38(5):MasterEditorial.qxd.qxd

  2010cites this paper
• Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells.

  2010cites this paper